COMMUNIQUÉS West-GlobeNewswire

G1 Therapeutics Announces Appointment of New Members to the Board of Directors
08/06/2018
RESEARCH TRIANGLE PARK, N.C., June 08, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced that Cynthia Schwalm and Willie Deese have been appointed to its [...]
Fennec Announces Results of Annual Meeting
08/06/2018
RESEARCH TRIANGLE PARK, N.C., June 08, 2018 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April [...]
Amicus Therapeutics Appoints President and COO Bradley L. Campbell to Board of Directors
08/06/2018
Directors Donald J. Hayden, Jr. and Craig A. Wheeler Re-Elected CRANBURY, N.J., June 08, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company focused on discovering, developing and [...]
XORTX Announces Filing of FDA pre-IND Meeting Request Letter
08/06/2018
CALGARY, Alberta, June 08, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat [...]
Emergent BioSolutions to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference
08/06/2018
GAITHERSBURG, Md., June 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will present a corporate overview and discuss recent [...]
Solon Eiendom ASA : LAST DAY OF SUBSCRIPTION PERIOD IN THE SUBSEQUENT OFFERING
08/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
Oasmia Pharmaceutical AB (publ) Year-end report for the financial year May 1, 2017 – April 30, 2018
08/06/2018
FOURTH QUARTER February 1, 2018 – April 30, 2018 Consolidated net sales amounted to TSEK 843 compared to TSEK 44 in the fourth quarter the previous year Operating loss was TSEK 28,017 compared to TSEK 37,411 in the [...]
Shire plc : Rule 2.9 Announcement
08/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 8 June 2018 Shire [...]
Celixir announces US FDA approval of the IND application for cell therapy Heartcel
08/06/2018
Celixir announces US FDA approval of the IND application for cell therapy Heartcel TM FDA IND and UK MHRA CTA approval both achieved in H1 2018 Potentially pivotal heart failure trial of up to 250 patients in the UK and [...]
Midatech Pharma US enrols first patient in Gelclair trial in stem cell transplant
08/06/2018
8 June 2018 Midatech Pharma PLC (“Midatech”, “Company” or “Group”) Midatech Pharma US enrols first patient in Gelclair® trial in stem cell transplant Patients now being enrolled at the Dana-Farber/Brigham and Women’s [...]
IBA SA : IBA Signs Contract to Install Cyclone® 70 System in Arizona, USA
08/06/2018
IBA Signs Contract to Install Cyclone ® 70 System in Arizona, USA Cyclotron to be dedicated to the production of radiopharmaceuticals for diagnosing and treating critical illnesses worldwide Louvain-la-Neuve, Belgium, [...]
IBA SA : IBA Signe un Contrat pour l'installation d'un Cyclotron 70 MeV en Arizona, États-Unis
08/06/2018
IBA Signe un Contrat pour l'installation d'un Cyclotron 70 MeV en Arizona, États-Unis Le Cyclotron sera dédié à la production de radiopharmaceutiques pour le diagnostic et le traitement de maladies graves à travers le [...]
Arbutus Strengthens Management Team With Appointment of David C. Hastings as New Chief Financial Officer
07/06/2018
VANCOUVER, British Columbia and WARMINSTER, Pa., June 07, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced [...]
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/06/2018
SOUTH SAN FRANCISCO, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
EDAP TMS SA : EDAP Announces FDA Clearance for Focal One®
07/06/2018
AUSTIN, TX, LYON, FRANCE -- JUNE 7, 2018 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the global leader in therapeutic ultrasound, today announced that it has received 510(k) clearance from the US Food and Drug [...]
Helix BioPharma Corp. Closes Private Placement
07/06/2018
RICHMOND HILL, Ontario, June 07, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Intercept to Present at Upcoming Conference
07/06/2018
NEW YORK, June 07, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Adamas to Present at Two Upcoming Investor Conferences
07/06/2018
EMERYVILLE, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that Gregory T. Went, Ph.D., the company’s Founder, Chairman and Chief Executive Officer, is scheduled to [...]
AIT Therapeutics Announces Change to Fiscal Year End and Financial Results Conference Call and Webcast for the Three Months Ended March 31, 2018
07/06/2018
Call scheduled for Thursday, June 14, 2018 at 8:30am Eastern Time NEW YORK, June 07, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled [...]

Pages